Novartis: 1996 – 2013 Dr Daniel Vasella was the first CEO of the newly merged company. Vasella was hired by Sandoz back in 1988 and remained there until 1992 when he was promoted to CEO of its ...

Novartis says it will scale up the use of Apple ResearchKit in clinical trials, as part of its efforts to bring about digital transformation across its business. Jacob LaPorte is global head of ...

Review the current valuation for Novartis AG ADR (NVS:XNYS) stock based on a yearly calendar providing PE ratios, cash flow, EBITDA and other company valuation information.

Review quarterly and annual revenue, net income, and cash flow for Novartis AG ADR (NVS:XNYS) stock through the last fiscal year.

Novartis announces commencement of tender offer to acquire Regulus Therapeutics. Basel, May 27, 2025 - Novartis today announced that Redwood Merger Sub Inc., a Delaware corporation and an indirect ...

Novartis India is trading 1.59% upper at Rs 1,014.85 as compared to its last closing price. Novartis India has been trading in the price range of 1,019.00 & 998.95. Novartis India has given 10.33% ...